Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2022-08-11 History
Report ID 158956
Drug Identification Number 00328154
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name ATROPINE SULFATE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 10mL LifeShield syringes
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-04-27
Estimated end date 2022-08-31
Actual end date 2022-08-10
Shortage status Resolved
Updated date 2022-08-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-08-11 English Compare
v13 2022-08-10 French Compare
v12 2022-08-10 English Compare
v11 2022-08-10 French Compare
v10 2022-08-10 English Compare
v9 2022-07-20 French Compare
v8 2022-07-20 English Compare
v7 2022-06-15 French Compare
v6 2022-06-15 English Compare
v5 2022-04-28 English Compare
v4 2022-04-27 French Compare
v3 2022-04-27 English Compare
v2 2022-04-18 French Compare
v1 2022-04-18 English Compare

Showing 1 to 14 of 14